PKCδ inhibition normalizes the wound-healing capacity of diabetic human fibroblasts.

MLA

Khamaisi, Mogher, et al. “PKCδ Inhibition Normalizes the Wound-Healing Capacity of Diabetic Human Fibroblasts.” The Journal of Clinical Investigation, vol. 126, no. 3, Mar. 2016, pp. 837–53. EBSCOhost, https://doi.org/10.1172/JCI82788.

APA

Khamaisi, M., Katagiri, S., Keenan, H., Park, K., Maeda, Y., Li, Q., Qi, W., Thomou, T., Eschuk, D., Tellechea, A., Veves, A., Huang, C., Orgill, D. P., Wagers, A., & King, G. L. (2016). PKCδ inhibition normalizes the wound-healing capacity of diabetic human fibroblasts. The Journal of Clinical Investigation, 126(3), 837–853. https://doi.org/10.1172/JCI82788

Chicago

Khamaisi, Mogher, Sayaka Katagiri, Hillary Keenan, Kyoungmin Park, Yasutaka Maeda, Qian Li, Weier Qi, et al. 2016. “PKCδ Inhibition Normalizes the Wound-Healing Capacity of Diabetic Human Fibroblasts.” The Journal of Clinical Investigation 126 (3): 837–53. doi:10.1172/JCI82788.